Artificial Intelligence in Life Sciences: Considerations for Policy-Making and Social Impact
Dr. Anand Konkala
Associate Professor of Zoology, Government City College (A), Nayapul, Hyderabad
Dr. G. Sadaya Kumar
Assistant Professor of Zoology, Tara Government Degree College, Sangareddy
Download PDF
http://doi.org/10.37648/ijps.v21i04.011
Abstract
Artificial intelligence (AI) is rapidly transforming life sciences by improving biological discovery, clinical diagnosis, drug development, epidemiological surveillance, precision medicine, and health-system efficiency. Its ability to process large and complex datasets has created new opportunities for faster and more accurate decision-making across laboratory research, public health, and patient care. However, the adoption of AI in life sciences raises important policy and social questions related to data governance, algorithmic bias, explainability, accountability, workforce adaptation, privacy, equity, and public trust. This review paper synthesises current applications of AI in life sciences and examines key governance challenges that must be addressed for socially responsible implementation. It argues that policy design should move beyond innovation promotion alone and include safeguards for fairness, transparency, safety, and inclusion. The paper proposes a policy framework centred on risk-based regulation, human oversight, quality standards for data and models, participatory governance, and ethical impact assessment. It also discusses the implications for low- and middle-income settings, where digital divides may amplify inequity if AI systems are not context-sensitive. A balanced approach to supporting innovation while protecting rights and social welfare is essential for ensuring that AI in life sciences contributes to public good rather than deepening existing disparities.
Keywords:
Artificial intelligence; Life sciences; Health policy; Ethics; Social impact; Data governance; Responsible innovation
References
- Ananya, K. V., Banerjee, N., Majumdar, S., & Prakya, V. (2025). Artificial intelligence in health care: Ethics, law and human rights matters — an overview of the 10th NBC proceedings. Indian Journal of Medical Ethics. https://doi.org/10.20529/IJME.2025.083
- Chatterjee, S. (2021). Artificial intelligence for healthcare in India: Policy, ethical and adoption issues. In IGI Global scholarly publication. IGI Global.
- Ferreira, F. J. N., et al. (2025). AI-driven drug discovery: A comprehensive review. Drug Discovery Today. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC12177741/
- Khalique, N., et al. (2024). The role of artificial intelligence in improving the public health system. Indian Journal of Community Medicine. https://journals.lww.com/ijcm/fulltext/9900/the_role_of_artificial_intelligence_in_improving.342.aspx
- McCradden, M. D., et al. (2020). Ethical limitations of algorithmic fairness solutions in health care machine learning. The Lancet Digital Health, 2(5), e221–e223. https://doi.org/10.1016/S2589-7500(20)30065-0
- Näher, A. F., et al. (2024). Measuring fairness preferences is important for artificial intelligence in health care. The Lancet Digital Health, 6(5), e300–e301. https://doi.org/10.1016/S2589-7500(24)00059-1
- Narayanan, R. R., Nagalakshmi, S., et al. (2022). Impact of artificial intelligence (AI) on drug discovery and product development of pharmaceuticals: A review. Indian Journal of Pharmaceutical Education and Research, 56(3s), S387–S396. https://doi.org/10.5530/ijper.56.3s.146
- OECD Council. (2019, amended 2024). Recommendation of the Council on Artificial Intelligence (OECD/LEGAL/0449). OECD Legal Instruments.
- OECD. (2024). OECD AI principles (originally adopted 2019). OECD AI Policy Observatory. https://www.oecd.org/en/topics/sub-issues/ai-principles.html
- Ueda, D., et al. (2023). Fairness of artificial intelligence in healthcare: Review and recommendations. Journal of Medical Internet Research, 25, e42979. https://doi.org/10.2196/42979
- World Health Organization (WHO). (2021). Ethics and governance of artificial intelligence for health. WHO.
- World Health Organization (WHO). (2025). Ethics and governance of artificial intelligence for health: Guidance on large multi-modal models (LMMs). WHO.
